Federal Register Notice: FDA’s Pharmacy Compounding Advisory Committee will meet 10/27, from 8 a.m. to 5:30 p.m., and on 10/28, from 8:30 a.m. to 4:45 p.m. at FDA White Oak Campus, 10903 New Hampshire Ave., Bldg. 31 Conference Center, the Great Room (Rm. 1503), Silver Spring, MD. On 10/27, the committee will discuss six bulk drug substances nominated for inclusion on the Section 503A bulk drug substances list: Quinacrine HCl, methylsulfonylmethane, curcumin, germanium sesquioxide, rubidium chloride, and deoxy-D-glucose. The nominators of these substances will be invited to make a short presentation supporting the nomination. On 10/28, the committee will discuss four bulk drug substances nominated for inclusion on the list: Alanyl-L-glutamine, glutaraldehyde, glycyrrhizin, and domperidone. Contact Cindy Hong, (301) 796-9001. To view this notice, click here.